Paul Hastings Advises CICC and Other Underwriters in PegBio’s Hong Kong IPO and Global Offering

May 27, 2025

Paul Hastings LLP advised China International Capital Corporation Hong Kong Securities Limited — the sole sponsor, overall coordinator, joint global coordinator, joint bookrunner and joint lead manager — and other underwriters on the US$38.67 million global offering and listing of PegBio Co., Ltd. on the Main Board of the Hong Kong Stock Exchange.

PegBio is a biotechnology company focused on the in-house discovery and development of innovative therapies — primarily peptide and small molecule drugs — for chronic diseases, with a particular emphasis on metabolic disorders.

Founding partner and chair of Greater China Raymond Li and corporate partners Chaobo Fan and Steven Hsu led the Paul Hastings team, which also included associates Iris Li and Wei You, China associate Jingyi Cao, legal managers Jin Cha and Zihan Shi, and paralegal Sunny Han.

About Paul Hastings

With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers and corporations. For more information, visit www.paulhastings.com.